CD58 and neoplasm: CD58 is involved in the immune recognition of the tumour cells via binding of the CD2 receptor expressed by most cytotoxic CD8+ T cells and NK cells: its downregulation further represent an immune escape mechanism of HL tumour cells, at least in the clinically aggressive disease [113,114].